Expression of small regions of equine herpesvirus 1 glycoprotein C in Escherichia coli.

The research article is about investigating the potential use of certain modified equine herpesvirus 1 (EHV1) molecules as antigens for the diagnosis of EHV1 and EHV4. These modified molecules were expressed in Escherichia coli bacteria, with some showing potential as diagnostic tools.

Overview of the Research Methodology and Findings

• The researchers conducted this study to explore the possible use of modified EHV1 glycoprotein C, an essential molecule of the virus, as a diagnostic marker for EHV1 and EHV4.
• The selected regions of EHV1 glycoprotein C were expressed in Escherichia coli bacteria. This type of bacteria is commonly used in scientific research to study genes and proteins due to its fast cultivation times and uncomplicated genetics.
• The expression process was done as a fusion with Glutathione S-transferase (GST), using the bacterial expression vector pGEX-2T. This is a strategy employed to enhance the stability of the protein and facilitate its purification. A bacterial expression vector helps to insert the gene of interest into bacteria for expression.
• The produced fusion proteins underwent testing using horse sera. The serum samples came from horses either exposed to EHV1, EHV4, or both, including samples from specific-pathogen-free (SPF) foals.
• The results showed that several fusion proteins encompassed EHV1 specific epitopes, which are the parts of an antigen that an antibody recognizes and binds to, while others had strong cross-reactive epitopes, signifying their potential in recognizing and binding to similar antigens in other pathogen types.
• One clone created, named pEC-3, produced a fusion protein that stood out as it was soluble and stable. It encompassed amino acids 107-275 of the EHV1 glycoprotein C, highlighting critical locus points for the interaction between the antigen and its corresponding antibody.
• The research findings indicated localized strong cross-reactive epitopes on amino acids 137 to approximately 152 of pEC-3. Meanwhile, EHV1 specific epitope(s) were identified downstream, around amino acids 152 to 275.
• The expressed EHV1 glycoprotein C polypeptides in E. coli showed clear potential for use as diagnostic reagents for the detection of cross-reactive and type-specific EHV1 and EHV4 antibodies present in the serum of horses that have previously been infected.

Implications of the Study

• This study contributes to improving diagnostic tools for equine herpesviruses. The identified epitopes of the truncated EHV1 glycoprotein C proteins could be implemented in diagnostic assays to accurately detect the presence of EHV1 and EHV4 antibodies.
• Moreover, identifying specific and cross-reactive epitopes may also assist in understanding the immune response against these pathogens, potentially shedding light on designing effective vaccines.